Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
7333 Mississauga Road, , ON, L5N 6L4, CA
Bora Pharmaceuticals is a full-service global CDMO specializing in the development and manufacturing of complex oral solid, liquid, semi-solid, ophthalmic, biologics, and sterile injectable pharmaceutical products for clinical and commercial use. Our comprehensive solutions and high-end global capacity enable our clients to deliver much-needed therapeutics to patients worldwide.
Explore how delivering therapeutic compounds and molecules via spheronized forms will support your most challenging drug product manufacturing goals.
Released By Bora Pharmaceuticals
Bora’s Technology Transfer Whitepaper will help you discover key strategies to successfully transfer and scale Rx & OTC drugs.
Multiple-unit pellet system (MUPS) can offer a solution to complex dose control
Synchronizing and controlling API delivery, E-S offers pharmaceutical companies a robust technique to manufacture today’s most complex therapeutics.
Agnus joins Bora Group from KBI Biopharma, where he led global business development.
By: Charlie Sternberg
Nelson Labs Nina Moreno shares insight on rapid sterility testing, the technologies used, advantages, and regulatory considerations.
Released By Nelson Laboratories, LLC
Enhances its capabilities in U.S. drug product manufacturing for aseptic filling of prefilled syringes & cartridges.
The merger transaction is expected to close mid-2025.
Enhances Roquette’s ability to deliver high-value drug delivery solutions to pharmaceutical customers worldwide.
Regulus’ lead asset, farabursen, is a potential first-in-class, next-gen oligonucleotide targeting miR-17 for the treatment of ADPKD.
L7 Informatics’ Marcia Blackmoore on how structured data, digital workflows, and real-time orchestration are helping CDMOs deliver at scale without compromising quality.
Released By L7 Informatics
Oviva's lead candidate, OVI-586, is a first-in-class therapeutic designed to enhance women's health span by extending ovarian function.
Will strengthen the presence of the Healthcare business of Merck KGaA, Darmstadt, Germany, in the United States.
Acquisition creates a large-scale manufacturing hub in the San Diego region with aseptic facilities for prefilled syringes, cartridges and high potent formulations.
Susan Lynch-Smith, Head of Business Development, Douglas CDMO, touts the advantages of and dispels misconceptions about mid-sized CDMOs.
Released By Douglas CDMO
Andrei Georgescu of Vivodyne discusses key advantages of its humanized drug testing platform and the impact of the FDA’s policy shift.
By: Kristin Brooks
Adds Dordaviprone to its oncology portfolio and advances its efforts to address unmet patient needs.
Cryoport Systems provides an end-to-end, next-gen approach to managing the complexities of the advanced therapy supply chain.
Released By Cryoport Systems
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
